invites you to a discussion with
Founding Member of the Women Inventors Subcommittee of Intellectual Property Owners (IPO) Women in Intellectual Property (IP) Committee
Click here to view the Gender Diversity in Innovation Toolkit.
Mercedes K. Meyer, Ph.D. opines on and oversees global patent portfolio management, development, strategy, investment, and acquisition. She has experience with due diligence, patent interferences, reexamination, drug pricing, patent prosecution ethics, and bioethics issues. Dr. Meyer helps clients protect innovations in such areas as antibodies, enzymes, viral vectors, genomics, nucleic acids, vaccines, stem cell research, gene therapy, drug screening, and identification, food and beverages, animal health products, and industrial enzymes for biofuels and cosmetics.
With a doctorate in virology from the University of Texas M.D. Anderson Cancer Center, a J.D. from the University of Houston Law Center, and a bachelor’s degree in chemistry from Bryn Mawr College, Dr. Meyer has an intimate understanding of complex biotechnology and chemical subjects. She collaborates with her life sciences clients from start-ups to Fortune 500 companies on their patent portfolio strategy and manages an extensive biotechnology and pharmaceutical patent prosecution practice, especially in corporate joint development projects. She also works with the boards of directors of start-ups for innovation monetization.
A strategic thinker, Dr. Meyer is familiar with issues relating to 35 U.S.C. §101 and subject-matter eligibility and 35 U.S.C. §203 Bayh-Dole march-in issues. She has also served as an expert in suits involving potential ethics violations arising from patent prosecution.
Dr. Meyer is an active member of the American Intellectual Property Law Association (AIPLA), where she was a former board member and secretary, and a current Chairperson of the Committee on the Profession, and of the Intellectual Property Owner’s Organization (IPO) Women’s Committee, IPO Education Foundation (IPOEF) Board Member, a former co-chair of the Diversity Committee of the Federal Circuit Bar Association, and the Association of University Technology Managers (AUTM) Women’s Inventor Committee. She is co-author of Patent Ethics: Prosecution (2016−2017, 4th edition) with David Hricik. Dr. Meyer is selected for inclusion on Managing Intellectual Property (IP) Stars, the IAM 300 Leading IP Strategists, and the IAM Patent 1000 World’s Leading Patent Practitioners lists.
Dr. Meyer’s talk is part of a series of speakers who have been invited by the Diversity and Inclusion Committee to visit the Law Center during the 2019-2020 academic year.